dipyridamole has been researched along with Antithrombin III Deficiency in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Antithrombin III Deficiency: An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccaccio, P | 1 |
| Ghio, R | 1 |
| Ratti, M | 1 |
| Casciaro, S | 1 |
| Rattenni, S | 1 |
| Sergnese, G | 1 |
| Kauffman, HM | 1 |
| Ekbom, GA | 1 |
| Adams, MB | 1 |
| Hussey, CV | 1 |
1 review available for dipyridamole and Antithrombin III Deficiency
| Article | Year |
|---|---|
[Disseminated intravascular coagulation. II. Therapeutic problems].
Topics: Antifibrinolytic Agents; Antithrombin III Deficiency; Anuria; Aprotinin; Aspirin; Blood Transfusion; | 1982 |
1 other study available for dipyridamole and Antithrombin III Deficiency
| Article | Year |
|---|---|
Hypercoagulability: a cause of vascular access failure.
Topics: Antithrombin III Deficiency; Aspirin; Dipyridamole; Humans; Intraoperative Period; Plasma; Renal Dia | 1979 |